Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2300
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorSOUZA, Alexandre Wagner Silva de-
dc.contributor.authorOKAMOTO, Karine Yoshiye Kajiyama-
dc.contributor.authorABRANTES, Fabiano-
dc.contributor.authorSCHAU, Bruno-
dc.contributor.authorBACCHIEGA, Ana Beatriz Santos-
dc.contributor.authorSHINJO, Samuel Katsuyuki-
dc.date.accessioned2013-09-23T16:50:41Z-
dc.date.available2013-09-23T16:50:41Z-
dc.date.issued2013-
dc.identifier.citationCLINICS, v.68, n.3, p.317-322, 2013-
dc.identifier.issn1807-5932-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2300-
dc.description.abstractOBJECTIVE: To describe demographic features, disease manifestations and therapy in patients with giant cell arteritis from referral centers in Brazil. METHODS: A retrospective cohort study was performed on 45 giant cell arteritis patients from three university hospitals in Brazil. Diagnoses were based on the American College of Rheumatology classification criteria for giant cell arteritis or temporal artery biopsy findings. RESULTS: Most patients were Caucasian, and females were slightly more predominant. The frequencies of disease manifestations were as follows: temporal headache in 82.2%, neuro-ophthalmologic manifestations in 68.9%, jaw claudication in 48.9%, systemic symptoms in 44.4%, polymyalgia rheumatica in 35.6% and extra-cranial vessel involvement in 17.8% of cases. Aortic aneurysms were observed in 6.6% of patients. A comparison between patients with biopsy-proven giant cell arteritis and those without temporal artery biopsies did not yield significant differences in disease manifestations. All patients were treated with oral prednisone, and intravenous methylprednisolone was administered to nearly half of the patients. Methotrexate was the most commonly used immunosuppressive agent, and low-dose aspirin was prescribed to the majority of patients. Relapses occurred in 28.9% of patients, and aspirin had a protective effect against relapses. Females had higher prevalences of polymyalgia rheumatica, systemic manifestations and jaw claudication, while permanent visual loss was more prevalent in men. CONCLUSIONS: Most of the clinical features of Brazilian giant cell arteritis patients were similar to those found in other studies, except for the high prevalence of neuro-ophthalmic manifestations and permanent blindness in the Brazilian patients. Aspirin had a protective effect on relapses.-
dc.language.isoeng-
dc.publisherHOSPITAL CLINICAS, UNIV SAO PAULO-
dc.relation.ispartofClinics-
dc.rightsopenAccess-
dc.subjectGiant Cell Arteritis-
dc.subjectGlucocorticoids-
dc.subjectMethotrexate-
dc.subjectMulticenter Study-
dc.subjectVasculitis-
dc.subject.othercranial ischemic complications-
dc.subject.otherpolymyalgia-rheumatica-
dc.subject.othertemporal arteritis-
dc.subject.othernorthwestern-spain-
dc.subject.otherclinical spectrum-
dc.subject.otheraortic-aneurysm-
dc.subject.othersex-differences-
dc.subject.otherrisk-factors-
dc.subject.othertherapy-
dc.subject.otherepidemiology-
dc.titleGiant cell arteritis: a multicenter observational study in Brazil-
dc.typearticle-
dc.rights.holderCopyright HOSPITAL CLINICAS, UNIV SAO PAULO-
dc.identifier.doi10.6061/clinics/2013(03)OA06-
dc.identifier.pmid23644850-
dc.subject.wosMedicine, General & Internal-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalSOUZA, Alexandre Wagner Silva de:Univ Fed Sao Paulo Unifesp EPM, Div Rheumatol, Sao Paulo, Brazil-
hcfmusp.author.externalOKAMOTO, Karine Yoshiye Kajiyama:Univ Fed Sao Paulo Unifesp EPM, Div Rheumatol, Sao Paulo, Brazil-
hcfmusp.author.externalABRANTES, Fabiano:Univ Fed Sao Paulo Unifesp EPM, Div Rheumatol, Sao Paulo, Brazil-
hcfmusp.author.externalSCHAU, Bruno:Univ Estado Rio de Janeiro, Div Rheumatol, BR-20550011 Rio De Janeiro, RJ, Brazil-
hcfmusp.author.externalBACCHIEGA, Ana Beatriz Santos:Univ Estado Rio de Janeiro, Div Rheumatol, BR-20550011 Rio De Janeiro, RJ, Brazil-
hcfmusp.description.beginpage317-
hcfmusp.description.endpage322-
hcfmusp.description.issue3-
hcfmusp.description.volume68-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000320000800007-
hcfmusp.origem.id2-s2.0-84878147880-
hcfmusp.origem.idSCIELO:S1807-59322013000300007-
hcfmusp.publisher.citySAO PAULO-
hcfmusp.publisher.countryBRAZIL-
hcfmusp.relation.referenceAlba MA, 2012, J CLIN RHEUM, V18, P21-
hcfmusp.relation.referenceANDERSSON R, 1986, ACTA MED SCAND, V220, P465-
hcfmusp.relation.referenceBENGTSSON BA, 1981, ARTHRITIS RHEUM, V24, P899, DOI 10.1002/art.1780240706-
hcfmusp.relation.referenceBorchers AT, 2012, AUTOIMMUN REV, V11, pA544, DOI 10.1016/j.autrev.2012.01.003-
hcfmusp.relation.referencedos Anjos DA, 2008, CLIN NUCL MED, V33, P402, DOI 10.1097/RLU.0b013e318170d46a-
hcfmusp.relation.referenceGodoy Pérsio, 2007, Arq Bras Cardiol, V88, pe84, DOI 10.1590/S0066-782X2007000400027-
hcfmusp.relation.referenceGonzalez-Gay MA, 2009, ARTHRIT CARE RES, V61, P1454, DOI 10.1002/art.24459-
hcfmusp.relation.referenceGonzalez-Gay MA, 2003, J RHEUMATOL, V30, P1548-
hcfmusp.relation.referenceGonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001-
hcfmusp.relation.referenceGonzalez-Gay MA, 2004, MEDICINE, V83, P335, DOI 10.1097/01.md.0000145366.40805.f8-
hcfmusp.relation.referenceHUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122-
hcfmusp.relation.referenceKLEIN RG, 1975, ANN INTERN MED, V83, P806-
hcfmusp.relation.referenceLee MS, 2006, ARTHRITIS RHEUM, V54, P3306, DOI 10.1002/art.22141-
hcfmusp.relation.referenceLopez-Diaz MJ, 2008, CLIN EXP RHEUMATOL, V26, pS16-
hcfmusp.relation.referenceMACHADO EBV, 1988, ARTHRITIS RHEUM, V31, P745, DOI 10.1002/art.1780310607-
hcfmusp.relation.referenceMahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754-
hcfmusp.relation.referenceMartinez-Lado L, 2011, MEDICINE, V90, P186, DOI 10.1097/MD.0b013e31821c4fad-
hcfmusp.relation.referenceMazlumzadeh M, 2006, ARTHRITIS RHEUM, V54, P3310, DOI 10.1002/art.22163-
hcfmusp.relation.referenceMonteiro Mário Luiz Ribeiro, 2006, Arq Bras Oftalmol, V69, P805, DOI 10.1590/S0004-27492006000600005-
hcfmusp.relation.referenceNarvaez J, 2002, J RHEUMATOL, V29, P321-
hcfmusp.relation.referenceNarvaez J, 2008, CLIN EXP RHEUMATOL, V26, pS57-
hcfmusp.relation.referenceNesher G, 2004, MEDICINE, V83, P114, DOI 10.1097/01.md.0000119761.27564.c9-
hcfmusp.relation.referenceNesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171-
hcfmusp.relation.referenceNir-Paz R, 2002, J RHEUMATOL, V29, P1219-
hcfmusp.relation.referenceNuenninghoff DM, 2003, ARTHRITIS RHEUM, V48, P3522, DOI 10.1002/art.11353-
hcfmusp.relation.referencePrieto-Gonzalez S, 2012, ANN RHEUM DIS, V71, P1170, DOI 10.1136/annrheumdis-2011-200865-
hcfmusp.relation.referenceProven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388-
hcfmusp.relation.referenceRichards BL, 2010, BEST PRACT RES CL RH, V24, P871, DOI 10.1016/j.berh.2010.10.008-
hcfmusp.relation.referenceSalvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6-
hcfmusp.relation.referenceSalvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P293, DOI 10.1002/art.21075-
hcfmusp.relation.referenceSalvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913-
hcfmusp.relation.referenceSALVARANI C, 1987, CLIN EXP RHEUMATOL, V5, P205-
hcfmusp.relation.referenceSCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus28-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia


Files in This Item:
File Description SizeFormat 
art_SHINJO_Giant_cell_arteritis_a_multicenter_observational_study_in_2013.PDFpublishedVersion (English)275.86 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.